Advertisement
Screener

ABEONA THERAPEUTICS INC. (ABEO) Auditor

ABEONA THERAPEUTICS INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-17: Fiscal year end 2025-12-31; Auditor Deloitte & Touche LLP; PCAOB firm ID 34; Location Morristown, New Jersey.
  • 2025-03-20: Fiscal year end 2024-12-31; Auditor Deloitte & Touche LLP; PCAOB firm ID 34; Location Morristown, New Jersey.
  • 2024-03-18: Fiscal year end 2023-12-31; Auditor Deloitte & Touche LLP; PCAOB firm ID 34; Location Morristown, New Jersey.
  • 2023-04-10: Fiscal year end 2022-12-31; Auditor WHITLEY PENN LLP; PCAOB firm ID 726; Location Plano, Texas.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-172025-12-31Deloitte & Touche LLP34Morristown, New JerseyNo
2025-03-202024-12-31Deloitte & Touche LLP34Morristown, New JerseyNo
2024-03-182023-12-31Deloitte & Touche LLP34Morristown, New JerseyNo
2023-04-102022-12-31WHITLEY PENN LLP726Plano, TexasNo
2023-03-292022-12-31WHITLEY PENN LLP726Plano, TexasNo
2022-03-312021-12-31WHITLEY PENN LLP726Plano, TexasNo
2021-03-242020-12-31WHITLEY PENN LLPNo
2020-03-162019-12-31WHITLEY PENN LLPPlano, Texas
2019-03-182018-12-31WHITLEY PENN LLPPlano, Texas
2018-03-162017-12-31WHITLEY PENN LLPDallas, Texas
2017-03-302016-12-31WHITLEY PENN LLPDallas, Texas
2016-03-302015-12-31WHITLEY PENN LLPDallas, Texas
2015-03-312014-12-31WHITLEY PENN LLPDallas, Texas
2014-03-262013-12-31WHITLEY PENN LLPDallas, Texas
2013-03-202012-12-31WHITLEY PENN LLPDallas, Texas
2012-03-232011-12-31WHITLEY PENN LLPDallas, Texas
2011-03-312010-12-31WHITLEY PENN LLPDallas, Texas
2010-03-232009-12-31WHITLEY PENN LLP
2009-03-312008-12-31WHITLEY PENN LLP

Similar stocks

Stock NameCountryMarket CapPE Ratio
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Evommune, Inc. (EVMN)United States$0.320B-5.10
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40